Dr. Thomas Dentzer
Director
Dr Thomas Dentzer holds a PhD in Virology from The Rockefeller University in New York and a Master’s degree in Biology from Albert-Ludwigs-Universität Freiburg im Breisgau in Germany. He has extensive experience and expertise in the field of public health in Luxembourg.
Before joining the LNS, Thomas Dentzer successively held the positions of postdoctoral researcher at the Luxembourg Institute of Health (LIH), consultant at Deloitte developing Healthcare & Life Sciences activities, Head of the Life Sciences sector at Luxinnovation and Director of the Luxembourg BioHealth Cluster. He also worked for the Directorate of Health, where he was responsible for coordination, strategic development, digital health and international relations, and served as a lecturer at the University of Luxembourg. During the COVID-19 pandemic, Thomas Dentzer was notably in charge of the national screening strategies in Luxembourg.
After serving for three years as Deputy Director and Chief Operating Officer (COO) of the LNS, Thomas Dentzer took over as Director in 2026. In this role, he was in charge of operations, coordinating and supporting the main business processes of the departments making up the multidisciplinary institute, with a focus on efficiency and performance. His remit also included quality and IT. He encouraged the implementation of digital approaches to improve both operational robustness and efficiency, while fostering a digital culture and data-driven approach within the LNS.
In addition to his activities at the LNS, Thomas Dentzer is actively involved in several organisations in the healthcare sector. In particular, he is co-leader of the National Task Force on Digital Health for Healthcare Transformation and serves as a board member of the European Centre for Disease Prevention and Control (ECDC), the European Health Emergency Response and Preparedness Authority (HERA) and the Standing Committee of the WHO Europe Regional Committee (SCRC).